Patents Assigned to Institute of Medical Support Technology, Academy of System Engineering, Academy of Military Science
  • Patent number: 11150458
    Abstract: The present invention discloses a multi-mode imaging optical system. The multi-mode imaging optical system includes a stage configured to hold a to-be-tested sample. An imaging unit implements in-situ imaging of the to-be-tested sample. An absorption and forward scattering illumination unit irradiates the to-be-tested sample, and forms absorption imaging or forward scattered light imaging in the imaging unit. A side scattering illumination unit performs a first oblique illumination on the to-be-tested sample, so that scattered light of microparticles in the to-be-tested sample forms side scattered light imaging in the imaging unit. A fluorescent illumination unit performs a second oblique illumination on the to-be-tested sample, and excites the microparticles in the to-be-tested sample to emit fluorescence, where the fluorescence forms fluorescence imaging in the imaging unit.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: October 19, 2021
    Assignee: INSTITUTE OF MEDICAL SUPPORT TECHNOLOGY, ACADEMY OF SYSTEM ENGINEERING, ACADEMY OF MILITARY SCIENCE
    Inventors: Chao Li, Meng Lv, Feng Chen, Yaohua Du, Zhi Cheng, Yanfei Yang, Meng Chen
  • Patent number: 11123452
    Abstract: The present invention relates to an alkyl chitosan-graphene oxide composite sponge and preparation method and application thereof. The alkyl chitosan-graphene oxide composite sponge provided by the present invention includes alkyl chitosan and graphene oxide absorbed on the alkyl chitosan, and the adsorbing capacity of the graphene oxide is 3-28 wt. %. In the present invention, alkyl chitosan is used as a matrix to combine graphene oxide and alkyl chitosan; the obtained composite sponge has excellent hemostatic performance and blood absorption capacity. Results of embodiments indicate that the in-vitro whole blood coagulation time is less than 58 s, the hemostasis time of a rabbit femoral artery hemorrhage model is less than 155 s, the hemorrhage mass is less than 5.4 g, and the hemostatic effect is superior to a pure alkyl chitosan sponge or graphene oxide powder when the composite sponge provided by the present invention is used for hemostasis.
    Type: Grant
    Filed: October 24, 2019
    Date of Patent: September 21, 2021
    Assignee: Institute of Medical Support Technology, Academy of System Engineering, Academy of Military Science
    Inventors: Jing Guan, Jian Yang, Ying Zhang, Feng Tian, Jimin Wu, Sheng Ding, Zhihong Li, Chunlai Wang
  • Publication number: 20200316248
    Abstract: The present invention relates to an alkyl chitosan-graphene oxide composite sponge and preparation method and application thereof. The alkyl chitosan-graphene oxide composite sponge provided by the present invention includes alkyl chitosan and graphene oxide absorbed on the alkyl chitosan, and the adsorbing capacity of the graphene oxide is 3-28 wt. %. In the present invention, alkyl chitosan is used as a matrix to combine graphene oxide and alkyl chitosan; the obtained composite sponge has excellent hemostatic performance and blood absorption capacity. Results of embodiments indicate that the in-vitro whole blood coagulation time is less than 58 s, the hemostasis time of a rabbit femoral artery hemorrhage model is less than 155 s, the hemorrhage mass is less than 5.4 g, and the hemostatic effect is superior to a pure alkyl chitosan sponge or graphene oxide powder when the composite sponge provided by the present invention is used for hemostasis.
    Type: Application
    Filed: October 24, 2019
    Publication date: October 8, 2020
    Applicant: Institute of Medical Support Technology, Academy of System Engineering, Academy of Military Science
    Inventors: Jing GUAN, Jian YANG, Ying ZHANG, Feng TIAN, Jimin WU, Sheng DING, Zhihong LI, Chunlai WANG